Fig. 3From: General public’s understanding of rare diseases and their opinions on medical resource allocation in Japan: a cross-sectional studyConditions required for the partial coverage of high-price rare disease medications. The respondents’ opinions regarding which conditions should be considered for the partial-cost coverage of high-price medications, such as ZolgensmaBack to article page